T. E. Barman

688 total citations
19 papers, 602 citations indexed

About

T. E. Barman is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Materials Chemistry. According to data from OpenAlex, T. E. Barman has authored 19 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Materials Chemistry. Recurrent topics in T. E. Barman's work include Cardiomyopathy and Myosin Studies (11 papers), Ion channel regulation and function (4 papers) and Enzyme Structure and Function (4 papers). T. E. Barman is often cited by papers focused on Cardiomyopathy and Myosin Studies (11 papers), Ion channel regulation and function (4 papers) and Enzyme Structure and Function (4 papers). T. E. Barman collaborates with scholars based in France, Germany and Hungary. T. E. Barman's co-authors include Franck Travers, Christian Herrmann, John L. Wray, Josep A. Biosca, H. Gutfreund, W. N. Aldridge, Chiara Tesi, Corinne Lionne, Dominique Mornet and Stephen E. Halford and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Biochemical Journal.

In The Last Decade

T. E. Barman

19 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. E. Barman France 14 391 257 127 61 50 19 602
Peter M.D. Hardwicke United States 14 559 1.4× 242 0.9× 102 0.8× 36 0.6× 33 0.7× 35 702
Hylary R. Trayer United Kingdom 19 703 1.8× 544 2.1× 180 1.4× 33 0.5× 69 1.4× 25 1.0k
Jean C. Grammer United States 17 470 1.2× 203 0.8× 141 1.1× 15 0.2× 26 0.5× 30 822
Stephen P. Chock United States 14 292 0.7× 140 0.5× 105 0.8× 28 0.5× 32 0.6× 28 565
Liselotte Plesner Denmark 14 392 1.0× 53 0.2× 53 0.4× 50 0.8× 34 0.7× 28 780
Anita S. Zot United States 9 444 1.1× 393 1.5× 79 0.6× 30 0.5× 43 0.9× 10 681
Jean‐Jacques Béchet France 15 388 1.0× 142 0.6× 97 0.8× 24 0.4× 15 0.3× 29 561
Lars Backman Sweden 17 459 1.2× 44 0.2× 199 1.6× 47 0.8× 42 0.8× 53 791
R C Lu United States 9 321 0.8× 191 0.7× 125 1.0× 13 0.2× 25 0.5× 10 431
Tom Barman France 14 349 0.9× 270 1.1× 52 0.4× 58 1.0× 43 0.9× 24 505

Countries citing papers authored by T. E. Barman

Since Specialization
Citations

This map shows the geographic impact of T. E. Barman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. E. Barman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. E. Barman more than expected).

Fields of papers citing papers by T. E. Barman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. E. Barman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. E. Barman. The network helps show where T. E. Barman may publish in the future.

Co-authorship network of co-authors of T. E. Barman

This figure shows the co-authorship network connecting the top 25 collaborators of T. E. Barman. A scholar is included among the top collaborators of T. E. Barman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. E. Barman. T. E. Barman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gondeau, Claire, Laurent Chaloin, Perrine Lallemand, et al.. (2008). Molecular basis for the lack of enantioselectivity of human 3-phosphoglycerate kinase. Nucleic Acids Research. 36(11). 3620–3629. 36 indexed citations
2.
Gautam, Rupesh K., et al.. (2006). Antimycobacterial Activities of Oxazolidinones: A Review. Infectious Disorders - Drug Targets. 6(4). 343–354. 35 indexed citations
3.
Barman, T. E., Stuart R.W. Bellamy, H. Gutfreund, Stephen E. Halford, & Corinne Lionne. (2006). The identification of chemical intermediates in enzyme catalysis by the rapid quench-flow technique. Cellular and Molecular Life Sciences. 63(22). 2571–2583. 30 indexed citations
4.
Lionne, Corinne, Christian Herrmann, Franck Travers, & T. E. Barman. (1995). The myofibril as a model for muscle fiber ATPase.. PubMed. 68(4 Suppl). 217S–217S. 2 indexed citations
5.
Herrmann, Christian, John L. Wray, Franck Travers, & T. E. Barman. (1992). Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor. Biochemistry. 31(48). 12227–12232. 194 indexed citations
6.
Travers, Franck, et al.. (1992). Calcium-activated myofibrillar ATPase: transient kinetics and the titration of its active sites. Biochemistry. 31(5). 1564–1569. 21 indexed citations
7.
Tesi, Chiara, et al.. (1991). Cryoenzymic studies on actomyosin ATPase: kinetic evidence for communication between the actin and ATP sites on myosin. Biochemistry. 30(16). 4061–4067. 16 indexed citations
8.
Tesi, Chiara, T. E. Barman, & Franck Travers. (1990). Is a four‐state model sufficient to describe actomyosin ATPase?. FEBS Letters. 260(2). 229–232. 13 indexed citations
9.
Guasch, Alı́cia, T. E. Barman, Franck Travers, & Claudi M. Cuchillo. (1989). Coupling of proteolytic quenching and high-performance liquid chromatography to enzyme reactions. Journal of Chromatography A. 473(1). 281–286. 10 indexed citations
10.
Tesi, Chiara, T. E. Barman, & Franck Travers. (1988). Sulphate is a competitive inhibitor of the binding of nucleotide to myosin A comparison with phosphate. FEBS Letters. 236(1). 256–260. 13 indexed citations
11.
Chaussepied, Patrick, Dominique Mornet, T. E. Barman, Franck Travers, & Ridha Kassab. (1986). Alteration of the ATP hydrolysis and actin binding properties of thrombin-cut myosin subfragment. Biochemistry. 25(5). 1141–1149. 23 indexed citations
12.
Biosca, Josep A., Franck Travers, T. E. Barman, et al.. (1985). Transient kinetics of ATP hydrolysis by covalently crosslinked actomyosin complex in water and 40% ethylene glycol by the rapid flow quench method. Biochemistry. 24(14). 3814–3820. 23 indexed citations
13.
Biosca, Josep A., et al.. (1984). Cryoenzymic studies on myosin subfragment 1: perturbation of an enzyme reaction by temperature and solvent. Biochemistry. 23(9). 1947–1955. 35 indexed citations
14.
15.
Biosca, Josep A., Franck Travers, & T. E. Barman. (1983). A jump in an Arrhenius plot can be the consequence of a phase transition. FEBS Letters. 153(1). 217–220. 37 indexed citations
16.
Barman, T. E., et al.. (1983). Evidence for the two-step binding of ATP to myosin subfragment 1 by the rapid-flow-quench method. Biochemical Journal. 209(3). 617–626. 30 indexed citations
17.
Mornet, Dominique, Elisabeth der Terrossian, L.A. Pradel, Rhida Kassab, & T. E. Barman. (1977). The reaction of myosin with a bromoalkyl analog of adenosine triphosphate. FEBS Letters. 84(2). 362–366. 7 indexed citations
18.
Barman, T. E.. (1974). Enzyme Handbook Supplement 1. 5 indexed citations
19.
Aldridge, W. N., T. E. Barman, & H. Gutfreund. (1964). The Rate of Formation and Decomposition of Phosphoryl-phosphatase (Escherichia coli). Biochemical Journal. 92(3). 23C–25C. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026